A carregar...
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
Major advances in understanding how genetics underlies Parkinson’s disease (PD) have provided new opportunities for understanding disease pathogenesis and potential new targets for therapeutic intervention. One such target is leucine-rich repeat kinase 2 (LRRK2), an enigmatic enzyme implicated in bo...
Na minha lista:
| Publicado no: | Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076802/ https://ncbi.nlm.nih.gov/pubmed/27799832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S102191 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|